Similar Papers

Paper Title
Journal
Date
Author
Venetoclax induces profound and sustained responses in patients with relapsed/refractory light-chain amyloidosis.
Hélène Pasquer ... Antoine Galat
British Journal of Haematology | VOL. 193
Hélène Pasquer, et. al.Hélène Pasquer ... Antoine Galat
13 Mar 2021
Quick consults in hematology: Staging and treating immunoglobulin light chain (AL) amyloidosis.
Morie Gertz
American journal of hematology | VOL. 98
Morie GertzMorie Gertz
12 May 2023
59-Year-Old Man With Fatigue, Weight Loss, and Hepatomegaly
Jacob J Orme ... Wilson I Gonsalves
Mayo Clinic Proceedings | VOL. 93
Jacob J Orme, et. al.Jacob J Orme ... Wilson I Gonsalves
10 Aug 2018
Cutaneous light chain amyloidosis with multiple myeloma: A concise review
Mirela Andrei ... Jen Chin Wang
Hematology/Oncology and Stem Cell Therapy | VOL. 12
Mirela Andrei, et. al.Mirela Andrei ... Jen Chin Wang
21 Sep 2018
View more papers

More From: Blood

Paper Title
Journal
Date
Author
Acute myeloid leukemia with BCL6 and KMT2A dual rearrangements
Qiudan Shen ... Shimin Hu
Blood | VOL. 145
Qiudan Shen, et. al.Qiudan Shen ... Shimin Hu
06 Feb 2025
The dark zone of CNS relapse in DLBCL
Kieron Dunleavy
Blood | VOL. 145
Kieron DunleavyKieron Dunleavy
06 Feb 2025
Impact of new medications on the treatment of Immune TTP.
Marie Scully ... William A Lester
Blood | VOL. -
Marie Scully, et. al.Marie Scully ... William A Lester
06 Feb 2025
No exit: targeting RNA export in T-cell malignancy
Katherine L B Borden
Blood | VOL. 145
Katherine L B BordenKatherine L B Borden
06 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.